PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.47%
Revenue growth 1.25-1.5x NXPI's 5.13%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
13.31%
Gross profit growth above 1.5x NXPI's 6.54%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.52%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
-6.84%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.70%
Negative net income growth while NXPI stands at 39.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.08%
Negative EPS growth while NXPI is at 40.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.45%
Negative diluted EPS growth while NXPI is at 39.53%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.54%
Reduced diluted shares while NXPI is at 0.59%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.31%
Dividend growth of 0.31% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
70.77%
OCF growth at 75-90% of NXPI's 86.25%. Bill Ackman would demand better working capital management or cost discipline.
77.99%
FCF growth 50-75% of NXPI's 134.00%. Martin Whitman would see if structural disadvantages exist in generating free cash.
100.90%
10Y revenue/share CAGR above 1.5x NXPI's 0.34%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
13.95%
5Y revenue/share CAGR above 1.5x NXPI's 0.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
-6.30%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
254.02%
10Y OCF/share CAGR under 50% of NXPI's 605.54%. Michael Burry would worry about a persistent underperformance in cash creation.
30.17%
Below 50% of NXPI's 605.54%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-5.66%
Negative 3Y OCF/share CAGR while NXPI stands at 79.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.73%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
32.93%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
-20.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
51.69%
Equity/share CAGR of 51.69% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
30.26%
Equity/share CAGR of 30.26% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
19.84%
3Y equity/share CAGR above 1.5x NXPI's 6.25%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
1205.79%
Dividend/share CAGR of 1205.79% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
179.73%
Dividend/share CAGR of 179.73% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.68%
3Y dividend/share CAGR of 132.68% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
2.21%
AR growth is negative/stable vs. NXPI's 6.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.35%
Inventory shrinking or stable vs. NXPI's 1.62%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.79%
Negative asset growth while NXPI invests at 7.12%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.48%
Under 50% of NXPI's 8.16%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.08%
We’re deleveraging while NXPI stands at 9.35%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-5.40%
Our R&D shrinks while NXPI invests at 5.16%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.27%
We cut SG&A while NXPI invests at 13.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.